EP2 receptor signaling pathways regulate classical activation of microglia

Journal of Biological Chemistry

Volumn 288, Issue 13, 2013, Pages 9293-9302

  Quan, Yi ^a   Jiang, Jianxiong ^a   Dingledine, Ray ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOXYMETHYL ESTERS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; INFLAMMATORY MEDIATORS; LIPOPOLYSACCHARIDES; PROTEIN EXPRESSIONS; PROTEIN MEASUREMENT; RECEPTOR SIGNALING; SIGNALING PATHWAYS;

ENCODING (SYMBOLS); PROTEINS;

CHEMICAL ACTIVATION;

CYCLIC AMP; CYCLOOXYGENASE 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 11; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROSTAGLANDIN E RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; INNATE IMMUNITY; MESSENGER RNA SYNTHESIS; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; INFLAMMATION; MICROGLIA; MODELS, BIOLOGICAL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84875992394     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.455816     Document Type: Article

References (59)

1. Hanisch, U. K., and Kettenmann, H. (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387-1394
2. Carson, M. J., Thrash, J. C., and Walter, B. (2006) The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin. Neurosci. Res. 6, 237-245
3. Kreutzberg, G. W. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318
4. Melchior, B., Puntambekar, S. S., and Carson, M. J. (2006) Microglia and the control of autoreactive T cell responses. Neurochem. Int. 49, 145-153
5. Garden, G. A., and Möller, T. (2006) Microglia biology in health and disease. J. Neuroimmune Pharmacol. 1, 127-137
6. Serrano, G. E., Lelutiu, N., Rojas, A., Cochi, S., Shaw, R., Makinson, C. D., Wang, D., FitzGerald, G. A., and Dingledine, R. (2011) Ablation of cyclooxygenase- 2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus. J. Neurosci. 31, 14850-14860
7. Yamagata, K., Andreasson, K. I., Kaufmann, W. E., Barnes, C. A., and Worley, P. F. (1993) Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11, 371-386
8. Murakami, M., Naraba, H., Tanioka, T., Semmyo, N., Nakatani, Y., Kojima, F., Ikeda, T., Fueki, M., Ueno, A., Oh, S., and Kudo, I. (2000) Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275, 32783-32792
9. Tanioka, T., Nakatani, Y., Semmyo, N., Murakami, M., and Kudo, I. (2000) Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J. Biol. Chem. 275, 32775-32782
10. Murakami, M., Nakashima, K., Kamei, D., Masuda, S., Ishikawa, Y., Ishii, T., Ohmiya, Y., Watanabe, K., and Kudo, I. (2003) Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J. Biol. Chem. 278, 37937-37947
11. Narumiya, S., Sugimoto, Y., and Ushikubi, F. (1999) Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79, 1193-1226
12. Cimino, P. J., Keene, C. D., Breyer, R. M., Montine, K. S., and Montine, T. J. (2008) Therapeutic targets in prostaglandin E2 signaling for neurologic disease. Curr. Med. Chem. 15, 1863-1869
13. Shi, J., Johansson, J., Woodling, N. S., Wang, Q., Montine, T. J., and Andreasson, K. (2010) The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity. J. Immunol. 184, 7207-7218
14. Caggiano, A. O., and Kraig, R. P. (1999) Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharideinduced interleukin-1β production. J. Neurochem. 72, 565-575
15. Aloisi, F., Penna, G., Cerase, J., Menéndez Iglesias, B., and Adorini, L. (1997) IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 159, 1604-1612
16. Menèndez Iglesias, B., Cerase, J., Ceracchini, C., Levi, G., and Aloisi, F. (1997) Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: upregulation by interferon-γ and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMPelevating agents. J. Neuroimmunol. 72, 83-93
17. Minghetti, L., Nicolini, A., Polazzi, E., Créminon, C., Maclouf, J., and Levi, G. (1997) Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors. Glia 19, 152-160
18. Aloisi, F., De Simone, R., Columba-Cabezas, S., and Levi, G. (1999) Opposite effects of interferon-γ and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities. J. Neurosci. Res. 56, 571-580
19. Cohen, P. (2002) Protein kinases-the major drug targets of the twentyfirst century? Nat. Rev. Drug Discov. 1, 309-315
20. Serezani, C. H., Ballinger, M. N., Aronoff, D. M., and Peters-Golden, M. (2008) Cyclic AMP: master regulator of innate immune cell function. Am. J. Respir. Cell Mol. Biol. 39, 127-132
21. Gloerich, M., and Bos, J. L. (2010) Epac: defining a new mechanism for cAMP action. Annu. Rev. Pharmacol. Toxicol. 50, 355-375
22. Shie, F. S., Breyer, R. M., and Montine, T. J. (2005) Microglia lacking E prostanoid receptor subtype 2 have enhanced Aβ phagocytosis yet lack Aβ-activated neurotoxicity. Am. J. Pathol. 166, 1163-1172
23. Jin, J., Shie, F. S., Liu, J., Wang, Y., Davis, J., Schantz, A. M., Montine, K. S., Montine, T. J., and Zhang, J. (2007) Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein. J. Neuroinflammation 4, 2
24. Liang, X., Wang, Q., Shi, J., Lokteva, L., Breyer, R. M., Montine, T. J., and Andreasson, K. (2008) The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis. Ann. Neurol. 64, 304-314
25. Shie, F. S., Montine, K. S., Breyer, R. M., and Montine, T. J. (2005) Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity. Glia 52, 70-77
26. Jiang, J., Quan, Y., Ganesh, T., Pouliot, W. A., Dudek, F. E., and Dingledine, R. (February 11, 2013) Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation. Proc. Natl. Acad. Sci. U.S.A. 10.1073/pnas.1218498110
27. Jiang, J., Ganesh, T., Du, Y., Thepchatri, P., Rojas, A., Lewis, I., Kurtkaya, S., Li, L., Qui, M., Serrano, G., Shaw, R., Sun, A., and Dingledine, R. (2010) Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor. Proc. Natl. Acad. Sci. U.S.A. 107, 2307-2312
28. Jiang, J., Ganesh, T., Du, Y., Quan, Y., Serrano, G., Qui, M., Speigel, I., Rojas, A., Lelutiu, N., and Dingledine, R. (2012) Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2. Proc. Natl. Acad. Sci. U.S.A. 109, 3149 -3154
29. Jiang, J., and Dingledine, R. (2013) Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation. J. Pharmacol. Exp. Ther. 344, 360-367
30. Quan, Y., Möller, T., and Weinstein, J. R. (2009) Regulation of Fcγ receptors and immunoglobulin G-mediated phagocytosis in mouse microglia. Neurosci. Lett. 464, 29-33
31. Quan, Y., Jiang, C. T., Xue, B., Zhu, S. G., and Wang, X. (2011) High glucose stimulates TNFα and MCP-1 expression in rat microglia via ROS and NF-κB pathways. Acta Pharmacol. Sin. 32, 188-193
32. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., and Speleman, F. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, RESEARCH0034
33. Weinstein, J. R., Zhang, M., Kutlubaev, M., Lee, R., Bishop, C., Andersen, H., Hanisch, U. K., and Möller, T. (2009) Thrombin-induced regulation of CD95(Fas) expression in the N9 microglial cell line: evidence for involvement of proteinase-activated receptor(1) and extracellular signal-regulated kinase 1/2. Neurochem. Res. 34, 445-452
34. Quan, Y., Du, J., and Wang, X. (2007) High glucose stimulates GRO secretion from rat microglia via ROS, PKC, and NF-κB pathways. J. Neurosci. Res. 85, 3150-3159
35. Martinez, F. O., Helming, L., and Gordon, S. (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27, 451-483
36. Kiriyama, M., Ushikubi, F., Kobayashi, T., Hirata, M., Sugimoto, Y., and Narumiya, S. (1997) Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br. J. Pharmacol. 122, 217-224
37. Billot, X., Chateauneuf, A., Chauret, N., Denis, D., Greig, G., Mathieu, M. C., Metters, K. M., Slipetz, D. M., and Young, R. N. (2003) Discovery of a potent and selective agonist of the prostaglandin EP4 receptor. Bioorg. Med. Chem. Lett. 13, 1129-1132
38. Abramovitz, M., Adam, M., Boie, Y., Carrière, M., Denis, D., Godbout, C., Lamontagne, S., Rochette, C., Sawyer, N., Tremblay, N. M., Belley, M., Gallant, M., Dufresne, C., Gareau, Y., Ruel, R., Juteau, H., Labelle, M., Ouimet, N., and Metters, K. M. (2000) The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim. Biophys. Acta 1483, 285-293
39. Engh, R. A., Girod, A., Kinzel, V., Huber, R., and Bossemeyer, D. (1996) Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity. J. Biol. Chem. 271, 26157-26164
40. Davies, S. P., Reddy, H., Caivano, M., and Cohen, P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105
41. Vliem, M. J., Ponsioen, B., Schwede, F., Pannekoek, W. J., Riedl, J., Kooistra, M. R., Jalink, K., Genieser, H. G., Bos, J. L., and Rehmann, H. (2008) 8-pCPT-2′-O-Me-cAMP-AM: an improved Epac-selective cAMP analogue. Chembiochem 9, 2052-2054
42. Chepurny, O. G., Leech, C. A., Kelley, G. G., Dzhura, I., Dzhura, E., Li, X., Rindler, M. J., Schwede, F., Genieser, H. G., and Holz, G. G. (2009) Enhanced Rap1 activation and insulin secretagogue properties of an acetoxymethyl ester of an Epac-selective cyclicAMPanalog in rat INS-1 cells: studies with 8-pCPT-2′-O-Me-cAMP-AM. J. Biol. Chem. 284, 10728-10736
43. Chen, H., Tsalkova, T., Mei, F. C., Hu, Y., Cheng, X., and Zhou, J. (2012) 5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP. Bioorg. Med. Chem. Lett. 22, 4038-4043
44. Almahariq, M., Tsalkova, T., Mei, F. C., Chen, H., Zhou, J., Sastry, S. K., Schwede, F., and Cheng, X. (2013) A novel EPAC specific inhibitor suppresses pancreatic cancer cell migration and invasion. Mol. Pharmacol. 83, 122-128
45. Dargahi, L., Nasiraei-Moghadam, S., Abdi, A., Khalaj, L., Moradi, F., and Ahmadiani, A. (2011) Cyclooxygenase (COX)-1 activity precedes the COX-2 induction in Aβ-induced neuroinflammation. J. Mol. Neurosci. 45, 10-21
46. Sánchez-Pernaute, R., Ferree, A., Cooper, O., Yu, M., Brownell, A. L., and Isacson, O. (2004) Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease. J. Neuroinflammation 1, 6
47. Kumar, A., Singh, R. L., and Babu, G. N. (2010) Cell death mechanisms in the early stages of acute glutamate neurotoxicity. Neurosci. Res. 66, 271-278
48. Chen, K., Northington, F. J., and Martin, L. J. (2010) Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice. Brain Struct. Funct. 214, 219-234
49. Tanaka, T., Katada, Y., Higa, S., Fujiwara, H., Wang, W., Saeki, Y., Ohshima, S., Okuda, Y., Suemura, M., and Kishimoto, T. (2001) Enhancement of T helper2 response in the absence of interleukin (IL-)6; an inhibition of IL-4-mediated T helper2 cell differentiation by IL-6. Cytokine 13, 193-201
50. Penkowa, M., Giralt, M., Carrasco, J., Hadberg, H., and Hidalgo, J. (2000) Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice. Glia 32, 271-285
51. Yamashita, M., Tsuji, S., Nishiyama, A., Myrvik, Q. N., Henriksen, R. A., and Shibata, Y. (2007) Differential subcellular localization of COX-2 in macrophages phagocytosing heat-killed Mycobacterium bovis BCG. Am. J. Physiol. Cell Physiol. 293, C184-C190
52. Foey, A. D., Parry, S. L., Williams, L. M., Feldmann, M., Foxwell, B. M., and Brennan, F. M. (1998) Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-α: role of the p38 and p42/44 mitogen-activated protein kinases. J. Immunol. 160, 920-928
53. De Lella Ezcurra, A. L., Chertoff, M., Ferrari, C., Graciarena, M., and Pitossi, F. (2010) Chronic expression of low levels of tumor necrosis factor-α in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation. Neurobiol. Dis. 37, 630-640
54. von Zahn, J., Möller, T., Kettenmann, H., and Nolte, C. (1997) Microglial phagocytosis is modulated by pro- and anti-inflammatory cytokines. Neuroreport 8, 3851-3856
55. Chavant, F., Deguil, J., Pain, S., Ingrand, I., Milin, S., Fauconneau, B., Pérault-Pochat, M. C., and Lafay-Chebassier, C. (2010) Imipramine, in part through tumor necrosis factor α inhibition, prevents cognitive decline and β-amyloid accumulation in a mouse model of Alzheimer's disease. J. Pharmacol. Exp. Ther. 332, 505-514
56. Ransohoff, R. M. (2009) Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 31, 711-721
57. Zambon, A. C., Zhang, L., Minovitsky, S., Kanter, J. R., Prabhakar, S., Salomonis, N., Vranizan, K., Dubchak, I., Conklin, B. R., and Insel, P. A. (2005) Gene expression patterns define key transcriptional events in cellcycle regulation by cAMP and protein kinase A. Proc. Natl. Acad. Sci. U.S.A. 102, 8561-8566
58. Aronoff, D. M., Carstens, J. K., Chen, G. H., Toews, G. B., and Peters- Golden, M. (2006) Short communication: differences between macrophages and dendritic cells in the cyclic AMP-dependent regulation of lipopolysaccharide- induced cytokine and chemokine synthesis. J. Interferon Cytokine Res. 26, 827-833
59. Liu, J., Zhao, X., Cao, J., Xue, Q., Feng, X., Liu, X., Zhang, F., and Yu, B. (2011) Differential roles of PKA and epac on the production of cytokines in the endotoxin-stimulated primary cultured microglia. J. Mol. Neurosci. 45, 186-193